Benchmark Capital upgrades Maxygen (Nasdaq: MAXY) from Hold to Buy.

Benchmark analyst says, "Maygen represents a unique opportunity, in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE